TrialHuman vaccines & immunotherapeutics2020

Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.

Gulbanu Sarsenbayeva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.